Literature DB >> 34195531

Patient and Provider Perspectives on Postsurgical Recovery of Cushing Syndrome.

Rachel Acree1, Caitlin M Miller1, Brent S Abel1, Nicola M Neary2, Karen Campbell3, Lynnette K Nieman1,2.   

Abstract

CONTEXT: Cushing syndrome (CS) is associated with impaired health-related quality of life (HRQOL) even after surgical cure.
OBJECTIVE: To characterize patient and provider perspectives on recovery from CS, drivers of decreased HRQOL during recovery, and ways to improve HRQOL.
DESIGN: Cross-sectional observational survey. PARTICIPANTS: Patients (n = 341) had undergone surgery for CS and were members of the Cushing's Support and Research Foundation. Physicians (n = 54) were Pituitary Society physician members and academicians who treated patients with CS.
RESULTS: Compared with patients, physicians underestimated the time to complete recovery after surgery (12 months vs 18 months, P = 0.0104). Time to recovery did not differ by CS etiology, but patients with adrenal etiologies of CS reported a longer duration of cortisol replacement medication compared with patients with Cushing disease (12 months vs 6 months, P = 0.0025). Physicians overestimated the benefits of work (26.9% vs 65.3%, P < 0.0001), exercise (40.9% vs 77.6%, P = 0.0001), and activities (44.8% vs 75.5%, P = 0.0016) as useful coping mechanisms in the postsurgical period. Most patients considered family/friends (83.4%) and rest (74.7%) to be helpful. All physicians endorsed educating patients on recovery, but 32.4% (95% CI, 27.3-38.0) of patients denied receiving sufficient information. Some patients did not feel prepared for the postsurgical experience (32.9%; 95% CI, 27.6-38.6) and considered physicians not familiar enough with CS (16.1%; 95% CI, 12.2-20.8).
CONCLUSION: Poor communication between physicians and CS patients may contribute to dissatisfaction with the postsurgical experience. Increased information on recovery, including helpful coping mechanisms, and improved provider-physician communication may improve HRQOL during recovery. Published by Oxford University Press on behalf of the Endocrine Society 2021.

Entities:  

Keywords:  Cushing’s syndrome; health-related quality of life; recovery

Year:  2021        PMID: 34195531      PMCID: PMC8240411          DOI: 10.1210/jendso/bvab109

Source DB:  PubMed          Journal:  J Endocr Soc        ISSN: 2472-1972


  39 in total

Review 1.  Diagnosis and complications of Cushing's syndrome: a consensus statement.

Authors:  G Arnaldi; A Angeli; A B Atkinson; X Bertagna; F Cavagnini; G P Chrousos; G A Fava; J W Findling; R C Gaillard; A B Grossman; B Kola; A Lacroix; T Mancini; F Mantero; J Newell-Price; L K Nieman; N Sonino; M L Vance; A Giustina; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

2.  Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL.

Authors:  Cornelie D Andela; Nicolasine D Niemeijer; Margreet Scharloo; Jitske Tiemensma; Shaaji Kanagasabapathy; Alberto M Pereira; Noëlle G A Kamminga; Ad A Kaptein; Nienke R Biermasz
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

3.  Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?

Authors:  M A E M Wagenmakers; R T Netea-Maier; J B Prins; T Dekkers; M den Heijer; A R M M Hermus
Journal:  Eur J Endocrinol       Date:  2012-08-30       Impact factor: 6.664

4.  Improvement but No Normalization of Quality of Life and Cognitive Functioning After Treatment of Cushing Syndrome.

Authors:  Leonie H A Broersen; Cornelie D Andela; Olaf M Dekkers; Alberto M Pereira; Nienke R Biermasz
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

5.  Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology.

Authors:  Christina M Berr; Guido Di Dalmazi; Andrea Osswald; Katrin Ritzel; Martin Bidlingmaier; Lucas L Geyer; Marcus Treitl; Klaus Hallfeldt; Walter Rachinger; Nicole Reisch; Rainer Blaser; Jochen Schopohl; Felix Beuschlein; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2014-12-29       Impact factor: 5.958

Review 6.  Neuropsychiatric disorders in Cushing's syndrome.

Authors:  Alberto M Pereira; Jitske Tiemensma; Johannes A Romijn
Journal:  Neuroendocrinology       Date:  2010-09-10       Impact factor: 4.914

7.  Long-term negative impact on quality of life in patients with successfully treated Cushing's disease.

Authors:  Adrian H Heald; Sandip Ghosh; Stephanie Bray; Christine Gibson; Simon G Anderson; Helen Buckler; Helen L Fowler
Journal:  Clin Endocrinol (Oxf)       Date:  2004-10       Impact factor: 3.478

8.  Evaluation of quality of life and anxiety and depression levels in patients receiving chemotherapy for colorectal cancer: impact of patient education before treatment initiation.

Authors:  Ulku Polat; Afey Arpacı; Satı Demir; Sevgi Erdal; Suayib Yalcin
Journal:  J Gastrointest Oncol       Date:  2014-08

9.  Evaluation of depression, quality of life and body image in patients with Cushing's disease.

Authors:  Nilufer Alcalar; Sedat Ozkan; Pinar Kadioglu; Ozlem Celik; Penbe Cagatay; Baris Kucukyuruk; Nurperi Gazioglu
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

Review 10.  Educational Interventions for Patients With CKD: A Systematic Review.

Authors:  Pamela A Lopez-Vargas; Allison Tong; Martin Howell; Jonathan C Craig
Journal:  Am J Kidney Dis       Date:  2016-03-26       Impact factor: 8.860

View more
  3 in total

Review 1.  Quality of life impairment after a diagnosis of Cushing's syndrome.

Authors:  Susan M Webb; Elena Valassi
Journal:  Pituitary       Date:  2022-06-29       Impact factor: 3.599

2.  Unmet needs in Cushing's syndrome: the patients' perspective.

Authors:  Elena Valassi; Iacopo Chiodini; Richard A Feelders; Cornelie D Andela; Margueritta Abou-Hanna; Sarah Idres; Antoine Tabarin
Journal:  Endocr Connect       Date:  2022-06-24       Impact factor: 3.221

Review 3.  Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome.

Authors:  Xin He; James W Findling; Richard J Auchus
Journal:  Pituitary       Date:  2022-04-26       Impact factor: 3.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.